A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-BASED RETROVIRAL VECTOR SYSTEM UTILIZING STABLE HIV-1 PACKAGING CELL-LINES

被引：46

作者：

CARROLL, R ^{[1
]}

LIN, JT ^{[1
]}

DACQUEL, EJ ^{[1
]}

MOSCA, JD ^{[1
]}

BURKE, DS ^{[1
]}

STLOUIS, DC ^{[1
]}

机构：

[1] WALTER REED ARMY INST RES,ROCKVILLE,MD 20850

来源：

JOURNAL OF VIROLOGY | 1994年 / 68卷 / 09期

关键词：

D O I：

10.1128/JVI.68.9.6047-6051.1994

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We have constructed stable human immunodeficiency virus (HIV) packaging cell lines that when transfected with an HIV-based retroviral vector produce packaged vectors capable of transducing susceptible CD4(+) cells. This HIV-1-based retroviral vector system has the potential for providing targeted delivery and regulated expression of immunogens or antiviral agents in CD4(+) cells.

引用

页码：6047 / 6051

页数：5

共 50 条

[41] THE DOT-IMMUNOBINDING TECHNIQUE IN DETECTION OF ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)
JANDA, WM
WILCOSKI, LM
TERRILE, L
MANDEL, K
NOVAK, D
STEVENS, JM
LABORATORY MEDICINE, 1995, 26 (02) : 131 - &
[42] EPOXY AND LOWICRYL EMBEDDING FOR LOCALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEINS IN VIRIONS
GOTO, T
MORITA, C
SUKENAGA, A
NAKAI, M
IKUTA, K
KATO, S
JOURNAL OF ELECTRON MICROSCOPY, 1990, 39 (04): : 280 - 280
[43] INTERACTIONS OF THYROID-HORMONE RECEPTOR WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) LONG TERMINAL REPEAT AND THE HIV-1 TAT TRANSACTIVATOR
DESAIYAJNIK, V
HADZIC, E
MODLINGER, P
MALHOTRA, S
GECHLIK, G
SAMUELS, HH
JOURNAL OF VIROLOGY, 1995, 69 (08) : 5103 - 5112
[44] A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION-ENHANCING FACTOR IN SEROPOSITIVE SERA
ROBINSON, WE
MONTEFIORI, DC
MITCHELL, WM
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (02) : 693 - 699
[45] A ROLE FOR THE ASPARTYL PROTEASE FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN THE ORCHESTRATION OF VIRUS ASSEMBLY
NAVIA, MA
MCKEEVER, BM
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 616 : 73 - 85
[46] ABNORMALITIES OF MEASLES ANTIBODY-RESPONSE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION
BRUNELL, PA
VIMAL, V
SANDHU, M
COURVILLE, TM
DAAR, E
ISRAELE, V
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (05): : 540 - 548
[47] ADVANTAGES OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PERSISTENTLY INFECTED HELA T4+-CELL LINE FOR HIV-1 INDIRECT IMMUNOFLUORESCENCE SEROLOGY
FORGHANI, B
HURST, JW
CHAN, CS
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (10) : 2266 - 2272
[48] EXERCISE AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) INFECTION
LAWLESS, D
JACKSON, CGR
GREENLEAF, JE
SPORTS MEDICINE, 1995, 19 (04) : 235 - 239
[49] TSAO DERIVATIVES - HIGHLY SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION
CAMARASA, MJ
PEREZPEREZ, MJ
VELAZQUEZ, S
SANFELIX, A
ALVAREZ, R
INGATE, S
JIMENO, ML
KARLSSON, A
DECLERCQ, E
BALZARINI, J
NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5): : 585 - 594
[50] UNLINKED ANONYMOUS SCREENING OF ANTENATAL PATIENTS FOR ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)
CHEW, CB
DOWNIE, JC
CUNNINGHAM, AL
MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (11) : 693 - 696

← 1 2 3 4 5 →